Research study Program year 2023 Source: CMS Open Payments

Riociguat replacing PDE5i therapy

Research payments

$307,903

90 payments

Through program year 2023, $307,903 in research payments was reported against Riociguat replacing PDE5i therapy, across 90 payments, paid by Bayer HealthCare Pharmaceuticals Inc..

Paid by
Bayer HealthCare Pharmaceuticals Inc.
ClinicalTrials.gov
No trial number was reported for this study

By program year

4 rows
Year Kind Amount Payments
2023 Research $18,207 3
2021 Research $18,131 10
2020 Research $156,216 41
2019 Research $115,349 36

Breakdown

Who paid Research payments · program years 2019–2023
  1. Bayer HealthCare Pharmaceuticals Inc. $307,903 90 payments
Who received the money Research payments · program years 2019–2023
  1. New York University Organisation paid for research $44,826 4 payments
  2. Pulmonary Associates Of Richmond Inc Organisation paid for research $42,022 6 payments
  3. Cleveland Clinic Florida Organisation paid for research $30,214 10 payments
  4. Uc Davis Medical Center Teaching hospital · CA $26,237 5 payments
  5. Nyu Winthrop Hospital Teaching hospital · NY $22,544 7 payments
  6. St. Vincent's Health System Inc. Dba St. Vincent's Healthcare Organisation paid for research $18,956 2 payments
  7. University Of Rochester Organisation paid for research $18,207 3 payments
  8. Strong Memorial Hospital Teaching hospital · NY $13,264 3 payments
  9. Henry Ford Hospital Teaching hospital · MI $8,468 4 payments
  10. Newark Beth Israel Medical Center Teaching hospital · NJ $8,254 9 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record